Search

Bausch Health Cos Inc

Closed

SectorHealthcare

5.65 -0.7

Overview

Share price change

24h

Current

Min

5.62

Max

5.76

Key metrics

By Trading Economics

Income

1.7B

260M

Sales

363M

2.9B

P/E

Sector Avg

13.286

56.432

EPS

1.26

Profit margin

9.116

Employees

20,300

EBITDA

1.7B

1B

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+58.17% upside

Dividends

By Acuity

Next Earnings

28 paź 2026

Market Stats

By TradingEconomics

Market Cap

541M

2.2B

Previous open

6.35

Previous close

5.65

News Sentiment

By Acuity

31%

69%

55 / 339 Ranking in Healthcare

Bausch Health Cos Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

17 wrz 2026, 23:56 UTC

Event
News

Rexford Industrial Realty completed a $1.2 billion sale of a 22-property portfolio to EQT Real Estate, with shares slightly declining in after-market trading.

17 wrz 2026, 23:41 UTC

News
Correlated Moves

Starwood Property Trust Inc announced a quarterly dividend of $0.48 per share, with shares moving higher in after-market trading following the announcement.

17 wrz 2026, 23:41 UTC

News
Correlated Moves
Macro Event

USD/HUF exchange rate is declining amid mixed macroeconomic signals, including a drop in U.S. initial jobless claims and weaker housing data.

17 wrz 2026, 23:26 UTC

News

Incyte Corp's stock is trading higher in after-market hours as investors await an FDA decision on zilurgisertib, with a target date of September 26.

17 wrz 2026, 23:16 UTC

News

Leonardo DRS, Inc. is higher in after-market trading following a contract with Doosan Enerbility to supply propulsion systems for South Korea's KDDX destroyer program.

17 wrz 2026, 23:16 UTC

News

Modine Manufacturing announces key merger dates and terms with Gentherm, including a $1.90 special cash dividend, as shares trade higher in after-market hours.

17 wrz 2026, 23:11 UTC

News

Cooper Companies shares are higher in after-market trading following insider purchases totaling $549K, despite calls for major changes from Jana Partners.

17 wrz 2026, 23:11 UTC

News

Enterprise Financial Services Corp shares declined in after-market trading following an Equal Weight rating initiation by Stephens analyst Brandon Rud.

17 wrz 2026, 23:11 UTC

News

Hercules Capital appointed Alfred B. Fichera to its Board of Directors, effective September 17, 2026, with stock trading modestly higher in after-market hours.

17 wrz 2026, 23:06 UTC

Social Media
News

Ultragenyx Pharmaceutical Inc. gained FDA approval for Fayuvi, the first gene therapy for Sanfilippo syndrome type A, driving after-market trading higher.

17 wrz 2026, 23:06 UTC

News

Coinbase Global Inc. shares are modestly lower in after-market trading as CEO Brian Armstrong declares the Clarity Act likely "dead" and explores alternative regulatory paths.

17 wrz 2026, 23:06 UTC

News

Twist Bioscience Corp's stock rises after a partnership with Eli Lilly's TuneLab, with Leerink raising its price target to $160 and increased fiscal 2026 sales guidance.

17 wrz 2026, 23:06 UTC

News
Correlated Moves
Macro Event

USD/SGD exchange rate is experiencing a slight decline, remaining roughly flat since Wednesday, amid mixed macroeconomic data impacting market sentiment.

17 wrz 2026, 23:06 UTC

Correlated Moves
News

The USD/CZK is trading lower, reflecting routine price movement despite recent strength, with little change since Wednesday's close.

17 wrz 2026, 23:01 UTC

Social Media
News

Xenon Pharmaceuticals submits a New Drug Application for azetukalner but pauses new patient enrollment in other studies, leading to a significant decline in after-hours trading.

17 wrz 2026, 23:01 UTC

News
Event

Nucor Corporation's after-market shares declined following third-quarter earnings guidance of $5.55 to $5.65 per share, below the consensus estimate of $6.20.

17 wrz 2026, 23:01 UTC

News

Walt Disney Co's stock is modestly higher in after-market trading following leadership changes aimed at enhancing its direct-to-consumer offerings.

17 wrz 2026, 23:01 UTC

News
Correlated Moves

Rithm Capital Corp declared a quarterly dividend of $0.25 per share, with the stock advancing in after-market trading following the announcement.

17 wrz 2026, 23:01 UTC

News

Campbell's Company extended the maturity date of its $1.85 billion credit agreement to April 16, 2031, and is modestly higher in after-market trading.

17 wrz 2026, 22:11 UTC

News

WBD's stock is trading modestly higher in after-market hours following FCC approval of foreign funding for the Paramount merger, enhancing operational synergies.

17 wrz 2026, 22:02 UTC

News

Agree Realty Corporation has priced $400 million in senior unsecured notes to enhance liquidity, with shares modestly higher in after-market trading.

17 wrz 2026, 22:01 UTC

Event
News

Steel Dynamics Inc issued Q3 2026 earnings guidance of $5.34 to $5.38 per share, below the $5.60 consensus, contributing to a decline in after-market trading.

17 wrz 2026, 21:31 UTC

News

BRT Apartments Corp. declared a $0.25 quarterly dividend and approved a $10 million share repurchase program, leading to gains in after-market trading.

17 wrz 2026, 20:31 UTC

News

Hub Group, Inc. declined in after-market trading following a Nasdaq delisting determination due to failure to file required reports, marking its lowest point since Thursday's close.

17 wrz 2026, 20:08 UTC

News

Shares of Scholar Rock Holding Corp fell modestly as the stock continues a five-session decline, despite FDA approval for its ISEMBYLD treatment.

17 wrz 2026, 20:08 UTC

Social Media
News

Dell Technologies Inc's market capitalization increased by $105 billion over 11 days, with the stock advancing today amid speculation of a price target of $630.

17 wrz 2026, 20:08 UTC

News
Correlated Moves
Social Media

Shares of Advanced Micro Devices advanced today on reports of planned price increases for GPUs and CPUs due to rising wafer costs from TSMC.

17 wrz 2026, 20:08 UTC

Correlated Moves
News

Cloudflare Inc. shares are higher today following Bernstein SocGen's price target increase, despite pulling back from a session high earlier.

17 wrz 2026, 20:08 UTC

News

Rivian's stock is trading higher as call volume reaches 27.1k contracts, indicating strong demand ahead of its earnings report on November 3rd.

17 wrz 2026, 20:08 UTC

Correlated Moves
Social Media
News

Marvell Technology's shares are advancing as it expands its agreement with GlobalFoundries to enhance silicon germanium capacity amid rising demand for optical connectivity products.

Peer Comparison

Price change

Bausch Health Cos Inc Forecast

Price Target

By TipRanks

58.17% upside

12 Months Forecast

Average 9 USD  58.17%

High 9 USD

Low 9 USD

Based on 1 Wall Street analysts offering 12 month price targets forBausch Health Cos Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

1 ratings

0

Buy

1

Hold

0

Sell

Sentiment

By Acuity

55 / 339 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Bausch Health Cos Inc

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
help-icon Live chat